Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Long-Term Deferred Tax (2024 - 2025)

TELA Bio has reported Long-Term Deferred Tax over the past 2 years, most recently at $62000.0 for Q3 2025.

  • Quarterly results put Long-Term Deferred Tax at $62000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $62000.0 (changed N/A YoY), and the annual figure for FY2024 was $140000.0, changed.
  • Long-Term Deferred Tax for Q3 2025 was $62000.0 at TELA Bio, down from $64000.0 in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for TELA hit a ceiling of $140000.0 in Q4 2024 and a floor of $62000.0 in Q3 2025.